期刊文献+

XELOX化疗方案致Stevens-Johnson综合征1例 被引量:2

原文传递
导出
摘要 报道1例XELOX化疗方案致Stevens-Johnson综合征(SJS)的病例。患者女性,58岁,因第4周期使用奥沙利铂(175mg,iv gtt,qd,第1天)联合卡培他滨(1500 mg,po,bid,第1~14天)化疗后出现全身皮疹2 d伴发热、腹泻入院。入院后被诊断为SJS。通过停用卡培他滨并积极使用糖皮质激素和注射用免疫球蛋白对症支持治疗,12 d后患者皮肤反应逐渐好转。临床药师结合患者的用药史采用Naranjo评估量表进行评分:奥沙利铂3分,有可能导致SJS;卡培他滨计5分,极有可能导致SJS。
出处 《中国临床药学杂志》 CAS 2022年第9期701-704,共4页 Chinese Journal of Clinical Pharmacy
作者简介 第一作者:郭凯,药师。研究方向:临床药学。E-mail:guokai1990@hotmail.com;通信作者:常莹莹,主管药师。研究方向:临床药学。E-mail:yychang_cindy@163.com
  • 相关文献

参考文献11

二级参考文献84

  • 1刘艳辉,刘江.重症药疹的治疗[J].医药世界,2006(8):88-89. 被引量:1
  • 2French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int, 2006, 55( 1 ): 9-16.
  • 3Paquet P, Pierard GE, Quatresooz P. Novel treatments for druginduced toxic epidermal necrolysis (Lyell's syndrome ). hat Arch Allergy Immunol, 2005, 136(3 ): 205-216.
  • 4Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol, 2000, 115(2): 149-153.
  • 5Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science, 1998, 282(5388): 490-493.
  • 6Stella M, Clemente A, Bollero D, et al. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. Bums, 2007, 33(4): 452-459.
  • 7Bastuji-Garin S, Rzany B, Stem RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol, 1993, 129 ( 1 ): 92-96.
  • 8Bastuji-Garin S, Fouchard N, Bertocehi M, et al. SCORTEN: a severity of illness score for toxic epidermal neerolysis. J Invest Dermatol, 2000, 115(2): 149-153.
  • 9Imahara SD, Holmes JH, Heirnbaeh DM, et al. SCORTEN Overestimates Mortality in the Setting of a Standardized Treatment Protocol. J Burn Care Res, 2006, 27(3 ): 270-275.
  • 10Cartotto R, Mayich M, Nickerson N, et al. SCORTEN Accurately Predicts Mortality Among Toxic Epidermal Neerolysis Patients Treated in a Burn Center. J Bum Care Res, 2008, 29 (1): 141-146.

共引文献201

同被引文献12

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部